AS-1501

N/A

Report date: 2025/04/30 15:19:27

Base Information

Drug NameAS-1501
Drug Alias NameAS-1501
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor ligand superfamily member 10 blockers
TargetsTumor necrosis factor ligand superfamily member 10
Therapy Area/IndicationsReperfusion InjuryMyocardial InfarctionHepatitis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Zhongke Amshenn Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShenzhen Zhongke Amshenn Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsReperfusion InjuryMyocardial InfarctionHepatitis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A